The global Renal and Biliary Stent System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Renal and Biliary Stent System refers to medical devices designed to keep passages in the renal (kidneys) and biliary (bile ducts) systems open. These stents are used to treat obstructions or narrowing of these passages, which can occur due to various conditions, such as tumors, stones, or strictures.

From a downstream perspective, Ureteral Obstruction accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Renal and Biliary Stent System leading manufacturers including Abbott, Boston Scientific, Medtronic, BD, Taewoong Medical (Olympus), Cook Medical, Merit Medical Systems, Nano Therapeutics, Meril Life, ELLA-CS, etc., dominate supply; the top five capture approximately % of global revenue, with Abbott leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Renal and Biliary Stent System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Renal and Biliary Stent System Market Report

Report Metric	Details
Report Name	Renal and Biliary Stent System Market
Segment by Type	Self-Expanding Stents Balloon-Expandable Stents Unmounted Stents
Segment by Application	Ureteral Obstruction Biliary Obstruction
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Boston Scientific, Medtronic, BD, Taewoong Medical (Olympus), Cook Medical, Merit Medical Systems, Nano Therapeutics, Meril Life, ELLA-CS, Blueneem Medical Devices, Sahajanand Medical Technologies, M.I. TECH, S&G Biotech, Micro-Tech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Renal and Biliary Stent System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Renal and Biliary Stent System Market report?

Ans: The main players in the Renal and Biliary Stent System Market are Abbott, Boston Scientific, Medtronic, BD, Taewoong Medical (Olympus), Cook Medical, Merit Medical Systems, Nano Therapeutics, Meril Life, ELLA-CS, Blueneem Medical Devices, Sahajanand Medical Technologies, M.I. TECH, S&G Biotech, Micro-Tech

What are the Application segmentation covered in the Renal and Biliary Stent System Market report?

Ans: The Applications covered in the Renal and Biliary Stent System Market report are Ureteral Obstruction, Biliary Obstruction

What are the Type segmentation covered in the Renal and Biliary Stent System Market report?

Ans: The Types covered in the Renal and Biliary Stent System Market report are Self-Expanding Stents, Balloon-Expandable Stents, Unmounted Stents

1 Study Coverage

1.1 Introduction to Renal and Biliary Stent System: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Renal and Biliary Stent System Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Self-Expanding Stents

1.2.3 Balloon-Expandable Stents

1.2.4 Unmounted Stents

1.3 Market Segmentation by Application

1.3.1 Global Renal and Biliary Stent System Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Ureteral Obstruction

1.3.3 Biliary Obstruction

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Renal and Biliary Stent System Revenue Estimates and Forecasts 2020-2031

2.2 Global Renal and Biliary Stent System Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Renal and Biliary Stent System Sales Estimates and Forecasts 2020-2031

2.4 Global Renal and Biliary Stent System Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Renal and Biliary Stent System Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Renal and Biliary Stent System Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Self-Expanding Stents Market Size by Manufacturers

3.5.2 Balloon-Expandable Stents Market Size by Manufacturers

3.5.3 Unmounted Stents Market Size by Manufacturers

3.6 Global Renal and Biliary Stent System Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Renal and Biliary Stent System Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Renal and Biliary Stent System Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Renal and Biliary Stent System Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Renal and Biliary Stent System Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Renal and Biliary Stent System Sales and Revenue by Type (2020-2031)

6.4 North America Renal and Biliary Stent System Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Renal and Biliary Stent System Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Renal and Biliary Stent System Sales and Revenue by Type (2020-2031)

7.4 Europe Renal and Biliary Stent System Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Renal and Biliary Stent System Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Renal and Biliary Stent System Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Renal and Biliary Stent System Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Renal and Biliary Stent System Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Renal and Biliary Stent System Sales and Revenue by Type (2020-2031)

9.4 Central and South America Renal and Biliary Stent System Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Renal and Biliary Stent System Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Renal and Biliary Stent System Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Renal and Biliary Stent System Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Renal and Biliary Stent System Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Abbott

11.1.1 Abbott Corporation Information

11.1.2 Abbott Business Overview

11.1.3 Abbott Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.1.4 Abbott Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 Abbott Renal and Biliary Stent System Sales by Product in 2024

11.1.6 Abbott Renal and Biliary Stent System Sales by Application in 2024

11.1.7 Abbott Renal and Biliary Stent System Sales by Geographic Area in 2024

11.1.8 Abbott Renal and Biliary Stent System SWOT Analysis

11.1.9 Abbott Recent Developments

11.2 Boston Scientific

11.2.1 Boston Scientific Corporation Information

11.2.2 Boston Scientific Business Overview

11.2.3 Boston Scientific Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.2.4 Boston Scientific Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Boston Scientific Renal and Biliary Stent System Sales by Product in 2024

11.2.6 Boston Scientific Renal and Biliary Stent System Sales by Application in 2024

11.2.7 Boston Scientific Renal and Biliary Stent System Sales by Geographic Area in 2024

11.2.8 Boston Scientific Renal and Biliary Stent System SWOT Analysis

11.2.9 Boston Scientific Recent Developments

11.3 Medtronic

11.3.1 Medtronic Corporation Information

11.3.2 Medtronic Business Overview

11.3.3 Medtronic Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.3.4 Medtronic Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Medtronic Renal and Biliary Stent System Sales by Product in 2024

11.3.6 Medtronic Renal and Biliary Stent System Sales by Application in 2024

11.3.7 Medtronic Renal and Biliary Stent System Sales by Geographic Area in 2024

11.3.8 Medtronic Renal and Biliary Stent System SWOT Analysis

11.3.9 Medtronic Recent Developments

11.4 BD

11.4.1 BD Corporation Information

11.4.2 BD Business Overview

11.4.3 BD Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.4.4 BD Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 BD Renal and Biliary Stent System Sales by Product in 2024

11.4.6 BD Renal and Biliary Stent System Sales by Application in 2024

11.4.7 BD Renal and Biliary Stent System Sales by Geographic Area in 2024

11.4.8 BD Renal and Biliary Stent System SWOT Analysis

11.4.9 BD Recent Developments

11.5 Taewoong Medical (Olympus)

11.5.1 Taewoong Medical (Olympus) Corporation Information

11.5.2 Taewoong Medical (Olympus) Business Overview

11.5.3 Taewoong Medical (Olympus) Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.5.4 Taewoong Medical (Olympus) Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Taewoong Medical (Olympus) Renal and Biliary Stent System Sales by Product in 2024

11.5.6 Taewoong Medical (Olympus) Renal and Biliary Stent System Sales by Application in 2024

11.5.7 Taewoong Medical (Olympus) Renal and Biliary Stent System Sales by Geographic Area in 2024

11.5.8 Taewoong Medical (Olympus) Renal and Biliary Stent System SWOT Analysis

11.5.9 Taewoong Medical (Olympus) Recent Developments

11.6 Cook Medical

11.6.1 Cook Medical Corporation Information

11.6.2 Cook Medical Business Overview

11.6.3 Cook Medical Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.6.4 Cook Medical Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Cook Medical Recent Developments

11.7 Merit Medical Systems

11.7.1 Merit Medical Systems Corporation Information

11.7.2 Merit Medical Systems Business Overview

11.7.3 Merit Medical Systems Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.7.4 Merit Medical Systems Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Merit Medical Systems Recent Developments

11.8 Nano Therapeutics

11.8.1 Nano Therapeutics Corporation Information

11.8.2 Nano Therapeutics Business Overview

11.8.3 Nano Therapeutics Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.8.4 Nano Therapeutics Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Nano Therapeutics Recent Developments

11.9 Meril Life

11.9.1 Meril Life Corporation Information

11.9.2 Meril Life Business Overview

11.9.3 Meril Life Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.9.4 Meril Life Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Meril Life Recent Developments

11.10 ELLA-CS

11.10.1 ELLA-CS Corporation Information

11.10.2 ELLA-CS Business Overview

11.10.3 ELLA-CS Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.10.4 ELLA-CS Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 ELLA-CS Recent Developments

11.11 Blueneem Medical Devices

11.11.1 Blueneem Medical Devices Corporation Information

11.11.2 Blueneem Medical Devices Business Overview

11.11.3 Blueneem Medical Devices Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.11.4 Blueneem Medical Devices Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Blueneem Medical Devices Recent Developments

11.12 Sahajanand Medical Technologies

11.12.1 Sahajanand Medical Technologies Corporation Information

11.12.2 Sahajanand Medical Technologies Business Overview

11.12.3 Sahajanand Medical Technologies Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.12.4 Sahajanand Medical Technologies Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 Sahajanand Medical Technologies Recent Developments

11.13 M.I. TECH

11.13.1 M.I. TECH Corporation Information

11.13.2 M.I. TECH Business Overview

11.13.3 M.I. TECH Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.13.4 M.I. TECH Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 M.I. TECH Recent Developments

11.14 S&G Biotech

11.14.1 S&G Biotech Corporation Information

11.14.2 S&G Biotech Business Overview

11.14.3 S&G Biotech Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.14.4 S&G Biotech Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.14.5 S&G Biotech Recent Developments

11.15 Micro-Tech

11.15.1 Micro-Tech Corporation Information

11.15.2 Micro-Tech Business Overview

11.15.3 Micro-Tech Renal and Biliary Stent System Product Models, Descriptions and Specifications

11.15.4 Micro-Tech Renal and Biliary Stent System Sales, Price, Revenue and Gross Margin (2020-2025)

11.15.5 Micro-Tech Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Renal and Biliary Stent System Industry Chain

12.2 Renal and Biliary Stent System Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Renal and Biliary Stent System Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Renal and Biliary Stent System Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Renal and Biliary Stent System Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Renal and Biliary Stent System Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Merit Medical Systems

Nano Therapeutics

Meril Life

ELLA-CS

Blueneem Medical Devices

Sahajanand Medical Technologies

M.I. Tech

S&G Biotech

Micro Tech

Taewoong Medical (Olympus)

List of Tables

Table 1. Global Renal and Biliary Stent System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Renal and Biliary Stent System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Renal and Biliary Stent System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Renal and Biliary Stent System Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Renal and Biliary Stent System Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Renal and Biliary Stent System Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Renal and Biliary Stent System Sales by Region (2020-2025) & (K Units)

Table 8. Global Renal and Biliary Stent System Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Renal and Biliary Stent System Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Renal and Biliary Stent System Sales Share by Manufacturers (2020-2025)

Table 12. Global Renal and Biliary Stent System Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Renal and Biliary Stent System Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Renal and Biliary Stent System by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal and Biliary Stent System as of 2024)

Table 16. Global Renal and Biliary Stent System Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Renal and Biliary Stent System Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Renal and Biliary Stent System Manufacturing Base and Headquarters

Table 19. Global Renal and Biliary Stent System Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Renal and Biliary Stent System Sales by Type (2020-2025) & (K Units)

Table 23. Global Renal and Biliary Stent System Sales by Type (2026-2031) & (K Units)

Table 24. Global Renal and Biliary Stent System Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Renal and Biliary Stent System Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Renal and Biliary Stent System ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Renal and Biliary Stent System Sales by Application (2020-2025) & (K Units)

Table 29. Global Renal and Biliary Stent System Sales by Application (2026-2031) & (K Units)

Table 30. Renal and Biliary Stent System High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Renal and Biliary Stent System Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Renal and Biliary Stent System Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Renal and Biliary Stent System ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Renal and Biliary Stent System Growth Accelerators and Market Barriers

Table 37. North America Renal and Biliary Stent System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Renal and Biliary Stent System Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Renal and Biliary Stent System Growth Accelerators and Market Barriers

Table 40. Europe Renal and Biliary Stent System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Renal and Biliary Stent System Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Renal and Biliary Stent System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Renal and Biliary Stent System Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Renal and Biliary Stent System Growth Accelerators and Market Barriers

Table 45. Southeast Asia Renal and Biliary Stent System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Renal and Biliary Stent System Investment Opportunities and Key Challenges

Table 47. Central and South America Renal and Biliary Stent System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Renal and Biliary Stent System Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Renal and Biliary Stent System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. Abbott Corporation Information

Table 51. Abbott Description and Major Businesses

Table 52. Abbott Product Models, Descriptions and Specifications

Table 53. Abbott Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. Abbott Sales Value Proportion by Product in 2024

Table 55. Abbott Sales Value Proportion by Application in 2024

Table 56. Abbott Sales Value Proportion by Geographic Area in 2024

Table 57. Abbott Renal and Biliary Stent System SWOT Analysis

Table 58. Abbott Recent Developments

Table 59. Boston Scientific Corporation Information

Table 60. Boston Scientific Description and Major Businesses

Table 61. Boston Scientific Product Models, Descriptions and Specifications

Table 62. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Boston Scientific Sales Value Proportion by Product in 2024

Table 64. Boston Scientific Sales Value Proportion by Application in 2024

Table 65. Boston Scientific Sales Value Proportion by Geographic Area in 2024

Table 66. Boston Scientific Renal and Biliary Stent System SWOT Analysis

Table 67. Boston Scientific Recent Developments

Table 68. Medtronic Corporation Information

Table 69. Medtronic Description and Major Businesses

Table 70. Medtronic Product Models, Descriptions and Specifications

Table 71. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Medtronic Sales Value Proportion by Product in 2024

Table 73. Medtronic Sales Value Proportion by Application in 2024

Table 74. Medtronic Sales Value Proportion by Geographic Area in 2024

Table 75. Medtronic Renal and Biliary Stent System SWOT Analysis

Table 76. Medtronic Recent Developments

Table 77. BD Corporation Information

Table 78. BD Description and Major Businesses

Table 79. BD Product Models, Descriptions and Specifications

Table 80. BD Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. BD Sales Value Proportion by Product in 2024

Table 82. BD Sales Value Proportion by Application in 2024

Table 83. BD Sales Value Proportion by Geographic Area in 2024

Table 84. BD Renal and Biliary Stent System SWOT Analysis

Table 85. BD Recent Developments

Table 86. Taewoong Medical (Olympus) Corporation Information

Table 87. Taewoong Medical (Olympus) Description and Major Businesses

Table 88. Taewoong Medical (Olympus) Product Models, Descriptions and Specifications

Table 89. Taewoong Medical (Olympus) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Taewoong Medical (Olympus) Sales Value Proportion by Product in 2024

Table 91. Taewoong Medical (Olympus) Sales Value Proportion by Application in 2024

Table 92. Taewoong Medical (Olympus) Sales Value Proportion by Geographic Area in 2024

Table 93. Taewoong Medical (Olympus) Renal and Biliary Stent System SWOT Analysis

Table 94. Taewoong Medical (Olympus) Recent Developments

Table 95. Cook Medical Corporation Information

Table 96. Cook Medical Description and Major Businesses

Table 97. Cook Medical Product Models, Descriptions and Specifications

Table 98. Cook Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Cook Medical Recent Developments

Table 100. Merit Medical Systems Corporation Information

Table 101. Merit Medical Systems Description and Major Businesses

Table 102. Merit Medical Systems Product Models, Descriptions and Specifications

Table 103. Merit Medical Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Merit Medical Systems Recent Developments

Table 105. Nano Therapeutics Corporation Information

Table 106. Nano Therapeutics Description and Major Businesses

Table 107. Nano Therapeutics Product Models, Descriptions and Specifications

Table 108. Nano Therapeutics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Nano Therapeutics Recent Developments

Table 110. Meril Life Corporation Information

Table 111. Meril Life Description and Major Businesses

Table 112. Meril Life Product Models, Descriptions and Specifications

Table 113. Meril Life Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Meril Life Recent Developments

Table 115. ELLA-CS Corporation Information

Table 116. ELLA-CS Description and Major Businesses

Table 117. ELLA-CS Product Models, Descriptions and Specifications

Table 118. ELLA-CS Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. ELLA-CS Recent Developments

Table 120. Blueneem Medical Devices Corporation Information

Table 121. Blueneem Medical Devices Description and Major Businesses

Table 122. Blueneem Medical Devices Product Models, Descriptions and Specifications

Table 123. Blueneem Medical Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Blueneem Medical Devices Recent Developments

Table 125. Sahajanand Medical Technologies Corporation Information

Table 126. Sahajanand Medical Technologies Description and Major Businesses

Table 127. Sahajanand Medical Technologies Product Models, Descriptions and Specifications

Table 128. Sahajanand Medical Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. Sahajanand Medical Technologies Recent Developments

Table 130. M.I. TECH Corporation Information

Table 131. M.I. TECH Description and Major Businesses

Table 132. M.I. TECH Product Models, Descriptions and Specifications

Table 133. M.I. TECH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 134. M.I. TECH Recent Developments

Table 135. S&G Biotech Corporation Information

Table 136. S&G Biotech Description and Major Businesses

Table 137. S&G Biotech Product Models, Descriptions and Specifications

Table 138. S&G Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 139. S&G Biotech Recent Developments

Table 140. Micro-Tech Corporation Information

Table 141. Micro-Tech Description and Major Businesses

Table 142. Micro-Tech Product Models, Descriptions and Specifications

Table 143. Micro-Tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 144. Micro-Tech Recent Developments

Table 145. Key Raw Materials Distribution

Table 146. Raw Materials Key Suppliers

Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 148. Milestones in Production Technology Evolution

Table 149. Distributors List

Table 150. Market Trends and Market Evolution

Table 151. Market Drivers and Opportunities

Table 152. Market Challenges, Risks, and Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Renal and Biliary Stent System Product Picture

Figure 2. Global Renal and Biliary Stent System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Self-Expanding Stents Product Picture

Figure 4. Balloon-Expandable Stents Product Picture

Figure 5. Unmounted Stents Product Picture

Figure 6. Global Renal and Biliary Stent System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. Ureteral Obstruction

Figure 8. Biliary Obstruction

Figure 9. Renal and Biliary Stent System Report Years Considered

Figure 10. Global Renal and Biliary Stent System Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Renal and Biliary Stent System Revenue (2020-2031) & (US$ Million)

Figure 12. Global Renal and Biliary Stent System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Renal and Biliary Stent System Revenue Market Share by Region (2020-2031)

Figure 14. Global Renal and Biliary Stent System Sales (2020-2031) & (K Units)

Figure 15. Global Renal and Biliary Stent System Sales (CAGR) by Region (2020-2031) (K Units)

Figure 16. Global Renal and Biliary Stent System Sales Market Share by Region (2020-2031)

Figure 17. Top 5 and Top 10 Manufacturers Renal and Biliary Stent System Sales Volume Market Share in 2024

Figure 18. Global Renal and Biliary Stent System Revenue Market Share Ranking (2024)

Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 20. Self-Expanding Stents Revenue Market Share by Manufacturer in 2024

Figure 21. Balloon-Expandable Stents Revenue Market Share by Manufacturer in 2024

Figure 22. Unmounted Stents Revenue Market Share by Manufacturer in 2024

Figure 23. Global Renal and Biliary Stent System Sales Market Share by Type (2020-2031)

Figure 24. Global Renal and Biliary Stent System Revenue Market Share by Type (2020-2031)

Figure 25. Global Renal and Biliary Stent System Sales Market Share by Application (2020-2031)

Figure 26. Global Renal and Biliary Stent System Revenue Market Share by Application (2020-2031)

Figure 27. North America Renal and Biliary Stent System Sales YoY (2020-2031) & (K Units)

Figure 28. North America Renal and Biliary Stent System Revenue YoY (2020-2031) & (US$ Million)

Figure 29. North America Top 5 Manufacturers Renal and Biliary Stent System Sales Revenue (US$ Million) in 2024

Figure 30. North America Renal and Biliary Stent System Sales Volume (K Units) by Type (2020- 2031)

Figure 31. North America Renal and Biliary Stent System Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 32. North America Renal and Biliary Stent System Sales Volume (K Units) by Application (2020-2031)

Figure 33. North America Renal and Biliary Stent System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 34. US Renal and Biliary Stent System Revenue (2020-2031) & (US$ Million)

Figure 35. Canada Renal and Biliary Stent System Revenue (2020-2031) & (US$ Million)

Figure 36. Mexico Renal and Biliary Stent System Revenue (2020-2031) & (US$ Million)

Figure 37. Europe Renal and Biliary Stent System Sales YoY (2020-2031) & (K Units)

Figure 38. Europe Renal and Biliary Stent System Revenue YoY (2020-2031) & (US$ Million)

Figure 39. Europe Top 5 Manufacturers Renal and Biliary Stent System Sales Revenue (US$ Million) in 2024

Figure 40. Europe Renal and Biliary Stent System Sales Volume (K Units) by Type (2020-2031)

Figure 41. Europe Renal and Biliary Stent System Sales Revenue (US$ Million) by Type (2020-2031)

Figure 42. Europe Renal and Biliary Stent System Sales Volume (K Units) by Application (2020-2031)

Figure 43. Europe Renal and Biliary Stent System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 44. Germany Renal and Biliary Stent System Revenue (2020-2031) & (US$ Million)

Figure 45. France Renal and Biliary Stent System Revenue (2020-2031) & (US$ Million)

Figure 46. U.K. Renal and Biliary Stent System Revenue (2020-2031) & (US$ Million)

Figure 47. Italy Renal and Biliary Stent System Revenue (2020-2031) & (US$ Million)

Figure 48. Russia Renal and Biliary Stent System Revenue (2020-2031) & (US$ Million)

Figure 49. Asia-Pacific Renal and Biliary Stent System Sales YoY (2020-2031) & (K Units)

Figure 50. Asia-Pacific Renal and Biliary Stent System Revenue YoY (2020-2031) & (US$ Million)

Figure 51. Asia-Pacific Top 8 Manufacturers Renal and Biliary Stent System Sales Revenue (US$ Million) in 2024

Figure 52. Asia-Pacific Renal and Biliary Stent System Sales Volume (K Units) by Type (2020- 2031)

Figure 53. Asia-Pacific Renal and Biliary Stent System Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 54. Asia-Pacific Renal and Biliary Stent System Sales Volume (K Units) by Application (2020-2031)

Figure 55. Asia-Pacific Renal and Biliary Stent System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 56. Indonesia Renal and Biliary Stent System Revenue (2020-2031) & (US$ Million)

Figure 57. Japan Renal and Biliary Stent System Revenue (2020-2031) & (US$ Million)

Figure 58. South Korea Renal and Biliary Stent System Revenue (2020-2031) & (US$ Million)

Figure 59. China Taiwan Renal and Biliary Stent System Revenue (2020-2031) & (US$ Million)

Figure 60. India Renal and Biliary Stent System Revenue (2020-2031) & (US$ Million)

Figure 61. Central and South America Renal and Biliary Stent System Sales YoY (2020-2031) & (K Units)

Figure 62. Central and South America Renal and Biliary Stent System Revenue YoY (2020-2031) & (US$ Million)

Figure 63. Central and South America Top 5 Manufacturers Renal and Biliary Stent System Sales Revenue (US$ Million) in 2024

Figure 64. Central and South America Renal and Biliary Stent System Sales Volume (K Units) by Type (2021-2031)

Figure 65. Central and South America Renal and Biliary Stent System Sales Revenue (US$ Million) by Type (2020-2031)

Figure 66. Central and South America Renal and Biliary Stent System Sales Volume (K Units) by Application (2020-2031)

Figure 67. Central and South America Renal and Biliary Stent System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 68. Brazil Renal and Biliary Stent System Revenue (2020-2025) & (US$ Million)

Figure 69. Argentina Renal and Biliary Stent System Revenue (2020-2025) & (US$ Million)

Figure 70. Middle East, and Africa Renal and Biliary Stent System Sales YoY (2020-2031) & (K Units)

Figure 71. Middle East and Africa Renal and Biliary Stent System Revenue YoY (2020-2031) & (US$ Million)

Figure 72. Middle East and Africa Top 5 Manufacturers Renal and Biliary Stent System Sales Revenue (US$ Million) in 2024

Figure 73. Middle East and Africa Renal and Biliary Stent System Sales Volume (K Units) by Type (2021-2031)

Figure 74. South America Renal and Biliary Stent System Sales Revenue (US$ Million) by Type (2020-2031)

Figure 75. Middle East and Africa Renal and Biliary Stent System Sales Volume (K Units) by Application (2020-2031)

Figure 76. Middle East and Africa Renal and Biliary Stent System Sales Revenue (US$ Million) by Application (2020-2031)

Figure 77. GCC Countries Renal and Biliary Stent System Revenue (2020-2025) & (US$ Million)

Figure 78. Turkey Renal and Biliary Stent System Revenue (2020-2025) & (US$ Million)

Figure 79. Egypt Renal and Biliary Stent System Revenue (2020-2025) & (US$ Million)

Figure 80. South Africa Renal and Biliary Stent System Revenue (2020-2025) & (US$ Million)

Figure 81. Renal and Biliary Stent System Industry Chain Mapping

Figure 82. Regional Renal and Biliary Stent System Manufacturing Base Distribution (%)

Figure 83. Global Renal and Biliary Stent System Production Market Share by Region (2020-2031)

Figure 84. Renal and Biliary Stent System Production Process

Figure 85. Regional Renal and Biliary Stent System Production Cost Structure

Figure 86. Channels of Distribution (Direct Vs Distribution)

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions